185 related articles for article (PubMed ID: 26066789)
1. Effects of sulfonylureas on lipids in type 2 diabetes mellitus: a meta-analysis of randomized controlled trials.
Chen YH; Du L; Geng XY; Peng YL; Shen JN; Zhang YG; Liu GJ; Sun X
J Evid Based Med; 2015 Aug; 8(3):134-48. PubMed ID: 26066789
[TBL] [Abstract][Full Text] [Related]
2. The effects of sulfonylureas plus metformin on lipids, blood pressure, and adverse events in type 2 diabetes: a meta-analysis of randomized controlled trials.
Zhang F; Xiang H; Fan Y; Ganchuluun TA; Kong W; Ouyang Q; Sun J; Cao B; Jiang H; Nie S
Endocrine; 2013 Dec; 44(3):648-58. PubMed ID: 23657947
[TBL] [Abstract][Full Text] [Related]
3. Sodium-Glucose Co-Transporter 2 Inhibitors Compared with Sulfonylureas in Patients with Type 2 Diabetes Inadequately Controlled on Metformin: A Meta-Analysis of Randomized Controlled Trials.
Chen Z; Li G
Clin Drug Investig; 2019 Jun; 39(6):521-531. PubMed ID: 31041606
[TBL] [Abstract][Full Text] [Related]
4. The effect of a dual combination of noninsulin antidiabetic drugs on lipids: a systematic review and network meta-analysis.
Dai X; Wang H; Jing Z; Fu P
Curr Med Res Opin; 2014 Sep; 30(9):1777-86. PubMed ID: 24805140
[TBL] [Abstract][Full Text] [Related]
5. Metformin and sulfonylureas in relation to cancer risk in type II diabetes patients: a meta-analysis using primary data of published studies.
Thakkar B; Aronis KN; Vamvini MT; Shields K; Mantzoros CS
Metabolism; 2013 Jul; 62(7):922-34. PubMed ID: 23419783
[TBL] [Abstract][Full Text] [Related]
6. Cancer risk of sulfonylureas in patients with type 2 diabetes mellitus: A systematic review.
Chen Y; Du L; Li L; Ma J; Geng X; Yao X; Liu G; Sun X
J Diabetes; 2017 May; 9(5):482-494. PubMed ID: 27273872
[TBL] [Abstract][Full Text] [Related]
7. Sulfonylureas: do we need to introspect safety again?
Sehra D; Sehra S; Sehra ST
Expert Opin Drug Saf; 2011 Nov; 10(6):851-61. PubMed ID: 21605015
[TBL] [Abstract][Full Text] [Related]
8. Real-life efficacy and safety of vildagliptin compared with sulfonylureas as add-on to metformin in patients with type 2 diabetes mellitus in Germany.
Göke R; Gruenberger JB; Bader G; Dworak M
Curr Med Res Opin; 2014 May; 30(5):785-9. PubMed ID: 24328429
[TBL] [Abstract][Full Text] [Related]
9. Meta-analysis of Atherogenic Index of Plasma and other lipid parameters in relation to risk of type 2 diabetes mellitus.
Zhu XW; Deng FY; Lei SF
Prim Care Diabetes; 2015 Feb; 9(1):60-7. PubMed ID: 24810146
[TBL] [Abstract][Full Text] [Related]
10. Comparison of lipid profiles and lipoprotein a levels in patients with type 2 diabetes mellitus during oral hypoglycemic or insulin therapy.
Habib SS; Aslam M; Naveed AK; Razi MS
Saudi Med J; 2006 Feb; 27(2):174-80. PubMed ID: 16501671
[TBL] [Abstract][Full Text] [Related]
11. Effects of Basal Insulin on Lipid Profile Compared to Other Classes of Antihyperglycemic Agents in Type 2 Diabetic Patients.
Rigato M; Avogaro A; Vigili de Kreutzenberg S; Fadini GP
J Clin Endocrinol Metab; 2020 Jul; 105(7):. PubMed ID: 32271381
[TBL] [Abstract][Full Text] [Related]
12. Capitalizing on prescribing pattern variation to compare medications for type 2 diabetes.
Prentice JC; Conlin PR; Gellad WF; Edelman D; Lee TA; Pizer SD
Value Health; 2014 Dec; 17(8):854-62. PubMed ID: 25498781
[TBL] [Abstract][Full Text] [Related]
13. Effects on lipid profile of dipeptidyl peptidase 4 inhibitors, pioglitazone, acarbose, and sulfonylureas: meta-analysis of placebo-controlled trials.
Monami M; Vitale V; Ambrosio ML; Bartoli N; Toffanello G; Ragghianti B; Monami F; Marchionni N; Mannucci E
Adv Ther; 2012 Sep; 29(9):736-46. PubMed ID: 22923161
[TBL] [Abstract][Full Text] [Related]
14. Effect of inulin-type fructans on blood lipid profile and glucose level: a systematic review and meta-analysis of randomized controlled trials.
Liu F; Prabhakar M; Ju J; Long H; Zhou HW
Eur J Clin Nutr; 2017 Jan; 71(1):9-20. PubMed ID: 27623982
[TBL] [Abstract][Full Text] [Related]
15. Effects of zinc supplementation on lipid profile in patients with type 2 diabetes mellitus: A systematic review and meta-analysis of randomized controlled trials.
Asbaghi O; Sadeghian M; Fouladvand F; Panahande B; Nasiri M; Khodadost M; Shokri A; Pirouzi A; Sadeghi O
Nutr Metab Cardiovasc Dis; 2020 Jul; 30(8):1260-1271. PubMed ID: 32451277
[TBL] [Abstract][Full Text] [Related]
16. A systematic review and meta-analysis of the serum lipid profile in prediction of diabetic neuropathy.
Cai Z; Yang Y; Zhang J
Sci Rep; 2021 Jan; 11(1):499. PubMed ID: 33436718
[TBL] [Abstract][Full Text] [Related]
17. PIOfix-study: effects of pioglitazone/metformin fixed combination in comparison with a combination of metformin with glimepiride on diabetic dyslipidemia.
Pfützner A; Schöndorf T; Tschöpe D; Lobmann R; Merke J; Müller J; Lehmann U; Fuchs W; Forst T
Diabetes Technol Ther; 2011 Jun; 13(6):637-43. PubMed ID: 21457065
[TBL] [Abstract][Full Text] [Related]
18. The effect of incident antidiabetic regimens on lipid profiles in veterans with type 2 diabetes: a retrospective cohort.
Roumie CL; Huizinga MM; Liu X; Greevy RA; Grijalva CG; Murff HJ; Hung AM; Griffin MR
Pharmacoepidemiol Drug Saf; 2011 Jan; 20(1):36-44. PubMed ID: 21182152
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of l-carnitine supplementation for management of blood lipids: A systematic review and dose-response meta-analysis of randomized controlled trials.
Askarpour M; Hadi A; Symonds ME; Miraghajani M; Omid Sadeghi ; Sheikhi A; Ghaedi E
Nutr Metab Cardiovasc Dis; 2019 Nov; 29(11):1151-1167. PubMed ID: 31561944
[TBL] [Abstract][Full Text] [Related]
20. Is gliclazide a sulfonylurea with difference? A review in 2016.
Singh AK; Singh R
Expert Rev Clin Pharmacol; 2016 Jun; 9(6):839-51. PubMed ID: 26924475
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
